Modeling the complex genetic architectures of brain disease

Michael B Fernando1,2,3,4, Tim Ahfeldt2,3,4,5,6,7, Kristen J Brennand8,9,10,11,12,13,14,15

  • 1Graduate School of Biomedical Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Nature Genetics
|March 24, 2020
PubMed
Summary

Understanding genetic risk variants for brain diseases requires advanced methods. Combining human induced pluripotent stem cells (hiPSCs) with CRISPR genome editing allows researchers to study gene combinations and complex disease biology for precision medicine.